ARTICLE | Clinical News
Humira adalimumab regulatory update
May 10, 2004 7:00 AM UTC
The EMEA recommended approval for a Humira label extension to include reducing the rate of progression of joint damage and improving physical function in adults with rheumatoid arthritis (RA). The mon...